Concepedia

Chihiro Ando

CA

10

Publications

194

Citations

10

H-Index

2017

Active since

Affiliations

Okayama University Hospital(Current)

Okayama University

Okayama Medical Center

Iwakuni Medical Center

National Hospital Organization

Chihiro Ando is an author at Okayama University Hospital specializing in medicine, lung cancer, and pathology.

ORCID

Top concepts

Publications per year

2017–2024

10

Publications

10

VEGFR2 blockade augments the effects of tyrosine kinase inhibitors by inhibiting angiogenesis and oncogenic signaling in oncogene‐driven non‐small‐cell lung cancers

Hiromi Watanabe, Eiki Ichihara, Hiroe Kayatani et al. · Cancer Science · 2021 · 47 citations · Full text

Age-related alteration in the distribution of methylglyoxal and its metabolic enzymes in the mouse brain

Shin Koike, Chihiro Ando, Yosuke Usui et al. · Brain Research Bulletin · 2018 · 27 citations

, , +8

CD8+ T-cell Responses Are Boosted by Dual PD-1/VEGFR2 Blockade after EGFR Inhibition in <i>Egfr</i> -Mutant Lung Cancer

Kazuya Nishii, Kadoaki Ohashi, Shuta Tomida et al. · Cancer Immunology Research · 2022 · 22 citations

Impacts of probiotics on the efficacies of immune checkpoint inhibitors with or without chemotherapy for patients with advanced non‐small‐cell lung cancer

Ayako Morita, Eiki Ichihara, Koji Inoue et al. · International Journal of Cancer · 2024 · 20 citations

Multiple Mucosa-associated Lymphoid Tissue Lymphoma of the Trachea

Daisuke Minami, Chihiro Ando, Ken Sato et al. · Internal Medicine · 2017 · 17 citations · Full text

, , +14

Rows per page

1–5 of 10